Farms.com Home   News

Will 2023 Be a Reset for Supply Chains?

The question’s been on everyone’s minds: what will supply chains and prices look like in the next year? That question carries a lot with it — what will seed prices look like for the next year? Will seed deliveries make it to their destination on time? Are there any other hiccups that could cause further disruptions?

While it’s impossible to read the future, two economic experts are helping us feel out for what supply chains are looking like in 2023 and how prices might affect the next growing season. Join us on Seed Speaks Wednesday, Aug. 17 at 12 p.m. CDT with expert speakers Michelle Klieger of Stratagerm Consulting and Barry Prentice of the University of Manitoba.

Klieger is an agricultural economist with 15 years of sector experience. She works with the key stakeholders in the global seed industry and ag tech companies, amongst others, as an economist and a business strategist. Klieger is a professor of economics at Bentley University, she holds a master’s in agriculture economics from Purdue University and a masters of business administration from Indiana University’s Kelley School of Business.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.